Lymph Cancer Antibodies

Lymphatic cancer generally refers to lymphoma, which is a malignant tumor originating from the lymphohematopoietic system. It can be divided into Hodgkin's lymphoma and non-Hodgkin's lymphoma, and it is a common tumor. The pathological features of Hodgkin's lymphoma are the neoplastic tissue containing lymphocytes, eosinophils, plasma cells, Reed Sternberg cell. The incidence of non-Hodgkin's lymphoma is much higher than That of Hodgkin's lymphoma, which is the sum total of a group of independent diseases with strong heterogeneity. Pathologically, non-Hodgkin's lymphoma is mainly lymphocytes, tissue cells or reticular cells with different degrees of differentiation. According to the different lymphocyte origin, it can be divided into B cell, T cell and NK cell lymphoma.

Elabscience^® has developed a batch of high quality lymphocancer-related antibodies, such as CD20, Galectin 3, LDHA and other indicators, which will help you to more accurately detect the expression level of important proteins.

View All the Lymph Cancer Antibodies>>